Review article highlights treatment advancements and underlying mechanisms in Alzheimer’s disease, suggesting new research directions.
ABSTRACT:Alzheimer 's disease (AD) is a progressive Neurodegenerative disorder characterized bycognitive decline, memory loss and functional impairment. AD is a complex multifactorialdisorder, influenced by both genetic and environmental factors. It is the most common causeof dementia globally and is clinically characterized by a progression from episodic memoryproblems to a slow general decline of cognitive function, our current understanding of ADpathologies involves various hypotheses such as cholinergic, amyloid, tau protein,Inflammatory, oxidative stress, metal ion, glutamate excitoxicity, microbiota-gut-brain axis,and abnormal autophagy and detailed information on signalling pathways linked to ADpathogenesis. This review mainly highlights the aetiology, clinical features, diagnosis andtreatment (pharmacological & non-pharmacological therapies) of people with Alzheimer'sdisease and also focussed on current Landscape in treatment Research for AD, Alzheimer'sDeng Development pipeline 2024.
No takes yet. Share an insight, caveat, or question.
Damarla et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: